6533b7dbfe1ef96bd12714a5

RESEARCH PRODUCT

Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma

Norma C. GutiérrezFelipe ProsperGorka AlkortaRafael MartínezFelipe De ArribaJosé De Jesús PérezFrancisco Javier Gracia-aznárezIbai GoicoecheaDiego AlignaniLeire BurgosNoemi PuigMaria-teresa CedenaJuan José LahuertaBruno PaivaMarcos GonzálezAlbert OriolMaria-jose CalasanzMaria-victoria MateosRaquel De PazAlberto OrfaoRafael Valdés-masCatarina MaiaJesús F. San MiguelJuana MerinoJoan BladéJoaquin Martinez-lopezSergio MatarrazCirino BottaLaura RosiñolM C ChillónAna-isabel TeruelMiguel T. HernandezLuis PalomeraIria VázquezRamón García-sanzSarai SarvideCristina MorenoPaula Martínez De Aguirre

subject

MaleOncologyPhysics::Instrumentation and Detectorsmedicine.medical_treatmentKaplan-Meier EstimateHematopoietic stem cell transplantationBiochemistryhemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsTumor MicroenvironmentProspective StudiesComputer Science::Operating SystemsIn Situ Hybridization FluorescenceMultiple myelomaRandomized Controlled Trials as TopicComputer Science::Cryptography and SecurityHazard ratioHematopoietic Stem Cell TransplantationHigh-Throughput Nucleotide SequencingHematologyMiddle AgedFlow CytometryPrognosisCombined Modality TherapyProgression-Free Survivalmedicine.anatomical_structureFemaleClonal HematopoiesisMultiple Myelomamedicine.medical_specialtyImmunologyTransplantation AutologousInternal medicinemedicineHumansClinical significanceProgression-free survivalComputer Science::Distributed Parallel and Cluster ComputingAgedAntineoplastic Combined Chemotherapy Protocolbusiness.industryCell Biologymedicine.diseaseTransplantationClinical Trials Phase III as TopicMyelodysplastic SyndromesMutationBone marrowbusinessMonoclonal gammopathy of undetermined significance

description

On behalf of the PETHEMA/GEM Cooperative Group.

10.1182/blood.2019003382http://hdl.handle.net/10261/222740